Education
|
|
1967-1971: Undergraduate Student, Biology, LeMoyne College, Syracuse, NY (B.S.)
|
|
|
1973-1978: Graduate Student, Biochemistry, Syracuse University, Syracuse, NY (Ph.D)
|
|
1978-1980: Post-doctoral Training Fellow, Clinical Chemistry, Mayo Clinic, Rochester, MN
|
|
Academic Appointments
|
|
2001-present: Senior Associate Dean for Research and Academic Affairs, University of Vermont College of Medicine, Burlington, VT
|
|
|
2000-2001: Interim Associate Dean for Research, University of Vermont College of Medicine, Burlington, VT
|
|
|
1997-present: Professor (with tenure) of Pathology and Biochemistry, University of Vermont College of Medicine, Burlington, VT
|
|
|
1995-1997: Associate Director of Clinical Chemistry, Fletcher Allen Health Care, Burlington, VT
|
|
|
1993-1997: Associate Professor (with tenure) of Pathology and Biochemistry, University of Vermont College of Medicine, Burlington, VT
|
|
|
1993-1995: Core Laboratory Director, General Clinical Research Center and Sims Obesity and Nutrition Research Center, University of Vermont College of Medicine, Burlington, VT
|
|
|
1988-1993: Assistant Professor (tenure track) of Pathology and Biochemistry, University of Vermont College of Medicine, Burlington, VT
|
|
|
1984-1995: Clinical Chemist, Medical Center Hospital of Vermont, Burlington, VT
|
|
|
1984-1988: Research Assistant Professor of Pathology and Biochemistry, University of Vermont College of Medicine, Burlington,VT
|
|
|
1983-1984: Assistant Professor of Pathology, University of Rochester, Rochester, NY
Assistant Director, Clinical Chemistry, Strong Memorial Hospital, Rochester, NY
|
|
|
1980-1983: Postdoctoral Research Fellow, Mayo Clinic, Rochester, MN
Consultant, Molecular Anatomy Program, Argonne National Laboratory, Argonne, IL
|
|
|
1978-1980: Postdoctoral Training Fellow in Clinical Chemistry, Mayo Clinic, Rochester, MN
|
|
Awards and Honors
|
|
Scholar Index (h Index) by Web of Science: 73 (8/2009); by Google Scholar: 78 (8/2009).
|
|
|
Highly cited articles include 2 in the top 50 most cited in "Arteriosclerosis, Thombosis and Vacular Biology" (current Impact Factor 7.2) and 2 in the top 50 most cited in Circulation (current Impact Factor 12.8).
|
|
|
University Distinguished Professor - highest academic award at the University of Vermont - 2009
|
|
|
The Bernie Zak Award for Research – Lipoproteins and Vascular Diseases Division, American Association for Clinical Chemistry – 2005.
|
|
The Kelly West Lecture – University of Oklahoma Medical Center – 2005.
|
|
|
Advisory Board member: Journal of Thrombosis and Haemostasis – 2004-present.
|
|
Fellow, American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology - 2001
|
|
|
Editorial Board Member: Arteriosclerosis, Thrombosis and Vascular Biology – 2000-present.
|
|
|
Third most cited article in Arteriosclerosis, Thrombosis and Vascular Biology: Tracy R, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Arterioscler. Thromb. Vasc. Biol. 1997;17:1121-1127 – awarded 2001
|
|
|
Distinguished Visiting Professor, Pathology Department, Emory University – 2001.
|
|
|
AACC Award for Outstanding Scientific Achievements by a Young Investigator; American Association for Clinical Chemistry and Boehringer Mannheim Diagnostics; 1984
|
|
|
Young Investigator Award - Academy of Clinical Laboratory Physicians and Scientists - 1979 and 1982.
|
|
Publications
|
|
Holvoet P*, Jenny NS, Schreiner PJ, Tracy RP, Jacobs DR. The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. In press, 2007.
|
|
|
Jenny NS*, Arnold AM, Kuller LH, Tracy RP, Psaty BM. Serum Amyloid P and Cardiovascular Disease in Older Men and Women. Results from the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. In press, 2007.
|
|
|
Jenny NS, Yanez ND, Psaty BM, Kuller LH, Hirsch CH, Tracy RP*. Inflammation biomarkers strongly predict near-term death in older men. Amer J Epidemiol In press, 2007.
|
|
|
Fitzpatrick AL*, Kronmal RA, Gardner JP, Psaty BM, Jenny NS, Tracy RP, Walston J, Kimura M, Aviv A. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol.165:14-21, 2007.
|
|
|
Holvoet P*, Harris TB, Tracy RP, Kritchevsky SB. Oxidized LDL and the metabolic syndrome. Letter to the Editor. Arterioscler Thromb Vasc Biol.26:e31, 2006 (author reply e31-2).
|
|
|
Lemaitre RN*, King IB, Mozaffarian D, Sotoodehnia N, Rea TD, Kuller LH, Tracy RP, Siscovick DS. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the cardiovascular health study. Circulation. 2006;114:209-15.
|
|
|
Festa A*, Williams K, Tracy RP, Wagenknecht LE, Haffner SM. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes. Circulation. 113(14):1753-9, 2006.
|
|
|
Reiner AP*, Carty CL, Carlson CS, Wan JY, Rieder MJ, Smith JD, Rice K, Fornage M, Jaquish CE, Williams OD, Tracy RP, Lewis CE, Siscovick DS, Boerwinkle E, Nickerson DA. Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study. J Thromb Haemost. 2006 Jun;4(6):1279-87.
|
|
|
DeKosky ST*, Fitzpatrick A, Ives DG, Saxton J, Williamson J, Lopez OL, Burke G, Fried L, Kuller LH, Robbins J, Tracy RP, Woolard N, Dunn L, Kronmal R, Nahin R, Furberg C for the GEMS Investigators. The Ginkgo Evaluation of Memory (GEM) study: Design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemporary Clin Trials 27 238–253 2006.
|
|
|
DeKosky ST*, Fitzpatrick A, Ives DG, Saxton J, Williamson J, Lopez OL, Burke G, Fried L, Kuller LH, Robbins J, Tracy RP, Woolard N, Dunn L, Kronmal R, Nahin R, Furberg C for the GEMS Investigators. The Ginkgo Evaluation of Memory (GEM) study: Design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemporary Clin Trials 27 238–253 2006.
|
|
|
Shlipak MG*, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B,. Psaty B, Tracy RP, Siscovick DS. The Prevalence and Impact of Preclinical Kidney Disease in the Elderly. Annals Int Med, 145:237-46, 2006.
|
|
Wadwa RP*, Kinney GL, Ogden L, Snell-Bergeon JK, Maahs DM, Cornell E, Tracy RP, Rewers M. Soluble Interleukin-2 Receptor as a Marker for Progression of Coronary Artery Calcification in Type 1 Diabetes. Int J Biochem Cell Biol. 38:996-1003, 2006.
|
|
McNeill AM*, Katz R, Girman CJ, Rosamond WD, Wagenknecht LE, Barzilay JI, Tracy RP, Savage PJ, Jackson SA. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study. J Am Geriatr Soc.54:1317-24, 2006.
|
|
|
Mehra R, Storfer-Isser A, Kirchner HL, Johnson N, Jenny N, Tracy RP, Redline S*. Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder. Arch Intern Med.166:1725-31, 2006.
|
|
|
Tracy RP*. Invited Editorial. The five cardinal signs of inflammation: Calor, Dolor, Rubor, Tumor ... and Penuria (Apologies to Aulus Cornelius Celsus, De medicina, c. A.D. 25). J Gerontol A Biol Sci Med Sci.61:1051-2, 2006.
|
|
|
Lange LA*, Carlson CS, Hindorff LA, Lange EM, Walston J, Durda P, Cushman M, Bis JC, Zeng D, Lin D, Kuller LH, Nickerson DA, Psaty BM, Tracy RP, Reiner AP*. Polymorphisms in the CRP gene are associated with circulating C-Reactive Protein levels and cardiovascular events: the Cardiovascular Health Study. JAMA 296:2703-11, 2006.
|
|
|
Bertoni AG*, Goff DC Jr, D'Agostino RB Jr, Liu K, Hundley WG, Lima JA, Polak JF, Saad MF, Szklo M, Tracy RP, Siscovick DS. Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 29:588-94, 2006.
|
|
|
Davidson M, Zhu J*, Lu W, Tracy RP, Robbins DC, Resnick HE, Ruotolo G, Howard BV and the Strong Heart Study Investigators. Plasminogen Activator Inhibitor-1 and the Risk of Type 2 Diabetes Mellitus in American Indians: the Strong Heart Study. Letter to the Editor. Diabet Med 23: 1158–1159, 2006.
|
|
|
Liu Y, Berthier-Schaad Y, Fallin MD, Fink NE, Tracy RP, Klag MJ, Smith MW, Coresh J*. IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol, 17:3158-66, 2006.
|
|
|
Hirsch C*, Anderson ML, Newman A, Kop W, Jackson S, Gottdiener J, Tracy R, Fried LP; for the Cardiovascular Health Study Research Group The Association of Race With Frailty: The Cardiovascular Health Study. Ann Epidemiol. In press, 2006.
|
|
|
Kuller LH*, Arnold AM, Psaty BM, Robbins JA, O'Leary DH, Tracy RP, Burke GL, Manolio TA, Chaves PH. 10-year follow-up of subclinical cardiovascular disease and risk of coronary heart disease in the Cardiovascular Health Study. Arch Intern Med. 166(1):71-8, 2006.
|
|
|
Jenny NS*, Arnold AM, Kuller LH, Sharrett AR, Fried LP, Psaty BM, Tracy RP. Soluble intracellular adhesion molecule-1 is associated with cardiovascular disease risk and mortality in older adults J Thromb Haemost. 4(1):107-13, 2006.
|
|
|
Cappola AR*, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW. Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults: The Cardiovascular Health Study. JAMA 295:1033-1041, 2006.
|
|
|
Sotoodehnia N, Siscovick DS, Vatta M, Psaty BM, Tracy RP, Towbin JA, Lemaitre RN, Rea TD, Durda JP, Chang JM, Lumley TS, Kuller LH, Burke GL, Heckbert SR*. Beta2-Adrenergic Receptor Genetic Variants and Risk of Sudden Cardiac Death. Circulation. 113(15):1842-8, 2006.
|
|
|
Friedlander Y*, Kark JD, Sinnreich R, Tracy RP, Siscovick DS. Fibrinogen and CRP in Israeli Families: Genetic and Environmental Sources of Concentrations and Longitudinal Changes. Atherosclerosis. 189:169-77, 2006.
|
|
|
Takamiya T*, Kadowaki T, Zaky WR, Ueshima H, Evans RW, Okamura T, Kashiwagi A, Nakamura Y, Kita Y, Tracy RP, Kuller LH, Sekikawa A. The determinants of plasma plasminogen activator inhibitor 1 levels differ for Americans and Japanese men aged 40-49. Diabetes Res Clin Prac. 72:176-82, 2006.
|
|
|
Toth MJ*, Ades PA, Lewinter MM, Tracy RP, Tchernof A. Skeletal muscle myofibrillar mRNA expression in heart failure: Relationship to local and circulating hormones. J Appl Physiol. 100:35-41, 2006.
|
|
|
Toth MJ*, Ades PA, Tischler MD, Tracy RP, LeWinter MM. Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure. International J Cardiol, 109:179-87, 2006.
|
|
|
